MedTrace Logo

Exploring the Influence of Glucagon-like Peptide -1 (GLP-1) Medications on Food Cravings, Food Selection, and Food Intake Following Exposure to Food Advertisements

NCT07505134 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-05-01

No results posted yet for this study

Summary

The purpose of this randomized control trial is to compare how food cravings, food selection, and food consumption change in response to frequent food advertisements compared to non-food advertisements in adults taking GLP-1 (weight loss) medications. The primary question we aim to answer is: do GLP-1 medications reduce an individual's vulnerability to external triggers that drive food cravings and consumption?

Participants will:

* report daily food consumption for a total of 10 days,
* receive eight daily prompts to view food or non-food related advertisements, and respond to a short 9-question survey for 7 days,
* answer several questionnaires,
* and complete two in-person visits to complete a virtual reality food selection task.

Conditions

  • GLP - 1

Interventions

BEHAVIORAL

Food advertisements

Videos and images of food and beverage advertisements from popular brands and/or restaurants

BEHAVIORAL

Tech advertisements

Video and photo advertisements of popular tech tools

Sponsors & Collaborators

  • Penn State Health

    collaborator UNKNOWN

  • Penn State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2026-08-31
Completion
2026-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07505134 on ClinicalTrials.gov